Vol 13, No 8 (August 31, 2024): Translational Lung Cancer Research

Editorial

The (un)lucky seven—how can we mitigate risk factors for postoperative pneumonia after lung resections?
Koen C. H. A. Verkoulen, Iris E. W. G. Laven, Jean H. T. Daemen, Juliette H. R. J. Degens, Lizza E. L. Hendriks, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Erik R. de Loos
Translational Lung Cancer Research  
2024;
13
(8)
:1763-1767
.

Original Article

Redefining YAP1 in small cell lung cancer: shifting from a dominant subtype marker to a favorable prognostic indicator
Se-Il Go, Jung Wook Yang, Eun Jeong Jeong, Woo Je Lee, Sungwoo Park, Dae Hyun Song, Gyeong-Won Lee
Translational Lung Cancer Research  
2024;
13
(8)
:1768-1779
.
Identifying genetically-supported drug repurposing targets for non-small cell lung cancer through mendelian randomization of the druggable genome
Yi Feng, Caichen Li, Bo Cheng, Ying Chen, Peiling Chen, Zixun Wang, Xiangyuan Zheng, Juan He, Feng Zhu, Wei Wang, Wenhua Liang
Translational Lung Cancer Research  
2024;
13
(8)
:1780-1793
.
CT-based radiomic consensus clustering association with tumor biological behavior in clinical stage IA adenocarcinoma: a retrospective study
Xin Wen, Meng-Wen Liu, Bin Qiu, Yan-Mei Wang, Jiu-Ming Jiang, Xue Zhang, Xu Jiang, Lin Li, Meng Li, Li Zhang
Translational Lung Cancer Research  
2024;
13
(8)
:1794-1806
.
Safety and efficacy of immunotherapy using a double-dose regimen in advanced non-small cell lung cancer (NSCLC): results of IDEE study
Clémence Pierre, Yannick Le Guen, Caroline Giordanengo, Thomas Goter, Hervé Léna, Clémence Niel, Gonzague De Chabot, Marie Tiercin, Gwenaelle Le Garff, François Zimmermann, Quentin Le Cornu, Charles Ricordel
Translational Lung Cancer Research  
2024;
13
(8)
:1807-1815
.
LungPath: artificial intelligence-driven histologic pattern recognition for improved diagnosis of early-stage invasive lung adenocarcinoma
Haoda Huang, Zeping Yan, Bingliang Li, Weixiang Lu, Ping He, Lei Fan, Xiaowei Wu, Hengrui Liang, Jianxing He
Translational Lung Cancer Research  
2024;
13
(8)
:1816-1827
.
Radiogenomics models for predicting prognosis in locally advanced non-small cell lung cancer patients undergoing definitive chemoradiotherapy
Xiaoyu Song, Li Li, Qingxi Yu, Ning Liu, Shouhui Zhu, Shuanghu Yuan
Translational Lung Cancer Research  
2024;
13
(8)
:1828-1840
.
A nomogram predicting the risk of extrathoracic metastasis at initial diagnosis of T≤3cmN0 lung cancer
Tengyong Wang, Zihuai Wang, Jian Zhou, Hui Jie, Hu Liao, Jiandong Mei, Qiang Pu, Lunxu Liu
Translational Lung Cancer Research  
2024;
13
(8)
:1841-1850
.
Effect of family history of cancer on postoperative survival in patients with non-small cell lung cancer
Jian Zhou, Quan Zheng, Yuchen Huang, Mengyuan Lyu, Tengyong Wang, Dongsheng Wu, Hu Liao
Translational Lung Cancer Research  
2024;
13
(8)
:1851-1861
.
Evaluation of the novel International Association for the Study of Lung Cancer grading system in adenocarcinoma with spread through air space
Kuan Xu, Yilv Lv, Tangbing Chen, Yuchen Han, Hanqing Huang, Hong Yu, Bo Ye
Translational Lung Cancer Research  
2024;
13
(8)
:1862-1876
.
Knowledge and beliefs about lung cancer screening among Black individuals at high risk: a qualitative approach
Abdi T. Gudina, Charles Kamen, Lindsey J. Mattick, Francisco Cartujano-Barrera, Michelle C. Janelsins, Deborah Ossip, M. Patricia Rivera, Kevin Fiscella, Ana-Paula Cupertino
Translational Lung Cancer Research  
2024;
13
(8)
:1877-1887
.
Prognostic and predictive significance of soluble programmed death ligand 1 in bronchoalveolar lavage fluid in stage IV non-small cell lung cancer
So-yun Kim, Dongil Park, Pureum Sun, Nayoung Kim, Dahye Lee, Duk Ki Kim, Song-I Lee, Jeong Eun Lee, Chaeuk Chung, Da Hyun Kang
Translational Lung Cancer Research  
2024;
13
(8)
:1888-1906
.
Assessing the transportability of radiomic models for lung cancer diagnosis: commercial vs. open-source feature extractors
David Xiao, Michael N. Kammer, Heidi Chen, Palina Woodhouse, Kim L. Sandler, Anna E. Baron, David O. Wilson, Ehab Billatos, Jiantao Pu, Fabien Maldonado, Stephen A. Deppen, Eric L. Grogan
Translational Lung Cancer Research  
2024;
13
(8)
:1907-1917
.
Emphysema and lung cancer risk
Agata Durawa, Katarzyna Dziadziuszko, Małgorzata Jelitto, Michał Gąsiorowski, Mariusz Kaszubowski, Edyta Szurowska, Witold Rzyman
Translational Lung Cancer Research  
2024;
13
(8)
:1918-1928
.
CYFRA 21-1 predicts efficacy of combined chemoimmunotherapy in patients with advanced non-small cell lung cancer: a prospective observational study
Nobutaka Kataoka, Yuki Katayama, Tadaaki Yamada, Kenji Morimoto, Takayuki Takeda, Asuka Okada, Shinsuke Shiotsu, Yusuke Chihara, Osamu Hiranuma, Takahiro Yamada, Takahiro Ota, Taishi Harada, Isao Hasegawa, Naoya Nishioka, Masahiro Iwasaku, Shinsaku Tokuda, Koichi Takayama
Translational Lung Cancer Research  
2024;
13
(8)
:1929-1937
.
Clinical features and prognostic biomarkers in patients with SMARCA4-mutated non-small cell lung cancer
Jinyu Long, Ying Chen, Xingguang Luo, Ruiying Rao, Chenxi Wang, Yuxin Guo, Jinhe Xu, Ping Lin, Yingfang Song, Lijuan Qu, Qinghong Liu, Jun Lu, Chengzhi Zhou, Zhengbo Song, Xiandong Lin, Hiroyuki Adachi, Jacek Jassem, Masatsugu Hamaji, Zongyang Yu
Translational Lung Cancer Research  
2024;
13
(8)
:1938-1949
.
Efficacy and prognostic factors of stereotactic body radiotherapy combined with immunotherapy for pulmonary oligometastases: a preliminary retrospective cohort study
Mei-Na Piao, Jing Xie, Min-Min Jin, Xiao-Ting Ma, Zheng Dou, Jian-Ping Wang, Jin-Li Li
Translational Lung Cancer Research  
2024;
13
(8)
:1950-1963
.
Effective induction immunotherapy minimizes surgical invasiveness for locally advanced lung cancer
Feichao Bao, Jiaming Wang, Chen Shen, Fenghao Yu, Marko Jakopović, Xiuxiu Hao, Yang Chen, Yiyang Wang, Zhitao Gu, Wentao Fang
Translational Lung Cancer Research  
2024;
13
(8)
:1964-1974
.
Prognostic role of dynamic changes in inflammatory indicators in patients with non-small cell lung cancer treated with immune checkpoint inhibitors—a retrospective cohort study
Liang Guo, Juanjuan Li, Jing Wang, Xinru Chen, Chenlei Cai, Fei Zhou, Anwen Xiong
Translational Lung Cancer Research  
2024;
13
(8)
:1975-1987
.
Single-center clinical experience of extended sleeve lobectomy (ESL) versus standard sleeve lobectomy (SL)
Haoyou Wang, Wei Wang, Peng Zu, Gregor J. Kocher, Mara B. Antonoff, Alberto Lopez-Pastorini, Chenlei Zhang, Wei Chen, Hongxu Liu
Translational Lung Cancer Research  
2024;
13
(8)
:1988-1999
.
Enhanced tumor targeting and penetration of fluorophores via iRGD peptide conjugation: a strategy for the precision targeting of lung cancer
Yunlong Li, Chenmei Li, Jiamin Li, Dong Han, Gang Xu, Daolong Zhu, Huiming Cai, Yiqing Wang, Dong Wang
Translational Lung Cancer Research  
2024;
13
(8)
:2000-2014
.
Efficacy of ALK inhibitors in Asian patients with ALK inhibitor-naïve advanced ALK-positive non-small cell lung cancer: a systematic review and network meta-analysis
Xuchang Li, Yangchen Xia, Chengyan Wang, Shanshan Huang, Qian Chu
Translational Lung Cancer Research  
2024;
13
(8)
:2015-2022
.
Neutrophil estimation and prognosis analysis based on existing lung squamous cell carcinoma datasets: the development and validation of a prognosis prediction model
Youyu Wang, Dongfang Li, Qiang Li, Alina Basnet, Jimmy T. Efird, Nobuhiko Seki
Translational Lung Cancer Research  
2024;
13
(8)
:2023-2037
.

Review Article

Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review
Mora Guardamagna, May-Lucie Meyer, Miguel Ángel Berciano-Guerrero, Andres Mesas-Ruiz, Manuel Cobo-Dols, Elisabeth Perez-Ruiz, Alexandra Cantero Gonzalez, Rocío Lavado-Valenzuela, Isabel Barragán, Javier Oliver, Alicia Garrido-Aranda, Martina Alvarez, Antonio Rueda-Dominguez, María Isabel Queipo-Ortuño, Emilio Alba Conejo, Jose Carlos Benitez
Translational Lung Cancer Research  
2024;
13
(8)
:2050-2066
.
Research into overcoming drug resistance in lung cancer treatment using CRISPR-Cas9 technology: a narrative review
Bin Liu, Ziyu Wang, Meng Gu, Jinghui Wang, Jinjing Tan
Translational Lung Cancer Research  
2024;
13
(8)
:2067-2081
.

Editorial Commentary

REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer?
Julie Dardare, Andréa Witz, Alexandre Harlé
Translational Lung Cancer Research  
2024;
13
(8)
:2082-2086
.
Are PD-1T TILs merely an expensive and unuseful whim as biomarker?
Esther Garcia-Lorenzo, Victor Moreno
Translational Lung Cancer Research  
2024;
13
(8)
:2087-2090
.
Can a dysfunctional T-cell gene signature predict nonresponse to PD-1 blockade in non-small cell lung cancer?
Hirokazu Taniguchi, Kazuto Ashizawa, Hiroshi Mukae
Translational Lung Cancer Research  
2024;
13
(8)
:2091-2094
.
Clinical insights: five-year follow-up of KEYNOTE-189 trial outcomes and more
Bobby Se, Athar Eysa, Nagla Karim
Translational Lung Cancer Research  
2024;
13
(8)
:2095-2097
.
Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development—are we close to the finish line?
Nagla Abdel Karim, Mohamed Zaza, Janakiraman Subramanian
Translational Lung Cancer Research  
2024;
13
(8)
:2098-2102
.